Daicel to market engineered formate dehydrogenase with NADPH regeneration capacity

Under the tradename of Chiralscreen™, Daicel is introducing a formate dehydrogenase which by protein engineering techniques has a high selectivity for NADPH regeneration. The development was done in collaboration with Prof. Koji ISHIHARA of Okayama University.

Daicel Exibition Information, JSBBA Meeting Sendai, March 27, 2013

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny